Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Hepatitis C virus-NS3P in relation to p53, p21waf, mdm2, p21-ras and c-erbB2 in hepatocarcinogenesis.

Bahnassi AA, Zekri AR, El-Houssini S, Mokhtar NM, Abdel-Aziz AO, Sherif GM, El-Mishad AM, Khaled HM.

J Gastroenterol Hepatol. 2005 Nov;20(11):1731-40.

PMID:
16246194
2.

Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival.

Bahnassy AA, Zekri AR, Abdallah S, El-Shehaby AM, Sherif GM.

Pathol Int. 2005 Feb;55(2):53-62.

PMID:
15693850
3.

[Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].

Yu GZ, Zhu MH, Ni CR, Li FM, Zheng JM, Gong ZJ.

Zhonghua Bing Li Xue Za Zhi. 2004 Apr;33(2):130-4. Chinese.

PMID:
15132849
4.

Correlation between expression of p53, p21/WAF1, and MDM2 proteins and their prognostic significance in primary hepatocellular carcinoma.

Zhang MF, Zhang ZY, Fu J, Yang YF, Yun JP.

J Transl Med. 2009 Dec 22;7:110. doi: 10.1186/1479-5876-7-110.

5.

[Expression and clinical significance of P53 pathway-associated proteins in pancreatic carcinoma].

Yu GZ, Zhu MH, Chen Y, Ni CR, Li FM.

Ai Zheng. 2005 Nov;24(11):1398-403. Chinese.

PMID:
16552971
6.

Correlation of TP53 mutations with HCV positivity in hepatocarcinogenesis: identification of a novel TP53 microindel in hepatocellular carcinoma with HCV infection.

Long J, Wang Y, Li M, Tong WM, Jia JD, Huang J.

Oncol Rep. 2013 Jul;30(1):119-24. doi: 10.3892/or.2013.2430. Epub 2013 Apr 26.

PMID:
23624687
7.

The Differential Immunohistochemical Expression of p53, c-Jun, c-Myc, and p21 Between HCV-related Hepatocellular Carcinoma With and Without Cirrhosis.

Abdou AG, Abd-Elwahed M, Badr M, Helmy M, Soliman EA, Maher D.

Appl Immunohistochem Mol Morphol. 2016 Feb;24(2):75-87. doi: 10.1097/PAI.0000000000000155.

PMID:
25710583
8.

Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.

Oda Y, Sakamoto A, Satio T, Kawauchi S, Iwamoto Y, Tsuneyoshi M.

Mod Pathol. 2000 Sep;13(9):994-1004.

9.

Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.

Ruggeri BA, Huang L, Berger D, Chang H, Klein-Szanto AJ, Goodrow T, Wood M, Obara T, Heath CW, Lynch H.

Cancer. 1997 Feb 15;79(4):700-16.

PMID:
9024708
10.
11.

Mdm2 and the p53 pathway in human pituitary adenomas.

Suliman M, Royds J, Cullen D, Timperley W, Powell T, Battersby R, Jones TH.

Clin Endocrinol (Oxf). 2001 Mar;54(3):317-25.

PMID:
11298083
12.

A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in liver cirrhosis and hepatocellular carcinoma.

Jablkowski M, Bocian A, Bialkowska J, Bartkowiak J.

J Exp Clin Cancer Res. 2005 Mar;24(1):117-25.

PMID:
15943041
13.
14.

Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis.

Edamoto Y, Hara A, Biernat W, Terracciano L, Cathomas G, Riehle HM, Matsuda M, Fujii H, Scoazec JY, Ohgaki H.

Int J Cancer. 2003 Sep 1;106(3):334-41.

15.

p21/Wafl/Cipl cellular expression in chronic long-lasting hepatitis C: correlation with HCV proteins (C, NS3, NS5A), other cell-cycle related proteins and selected clinical data.

Kasprzak A, Adamek A, Przybyszewska W, Olejniczak K, Biczysko W, Mozer-Lisewska I, Zabel M.

Folia Histochem Cytobiol. 2009 Jan;47(3):385-94. doi: 10.2478/v10042-009-0096-x.

16.

Molecular analysis of p53, MDM2 and H-ras genes in low-grade central osteosarcoma.

Park HR, Jung WW, Bertoni F, Bacchini P, Park JH, Kim YW, Park YK.

Pathol Res Pract. 2004;200(6):439-45.

PMID:
15310147
17.

Alteration of p53 and p21 during hepatocarcinogenesis in tree shrews.

Su JJ, Ban KC, Li Y, Qin LL, Wang HY, Yang C, Ou C, Duan XX, Lee YL, Yang RQ.

World J Gastroenterol. 2004 Dec 15;10(24):3559-63.

18.

p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis in aggressive non-Hodgkin's lymphomas.

Pagnano KB, Vassallo J, Lorand-Metze I, Costa FF, Saad ST.

Am J Hematol. 2001 Jun;67(2):84-92. Erratum in: Am J Hematol 2001 Aug;67(4):279.

19.
20.

Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma.

Shieh YS, Nguyen C, Vocal MV, Chu HW.

Int J Cancer. 1993 Jun 19;54(4):558-62.

PMID:
8390407

Supplemental Content

Support Center